Autolus Therapeutics plc AUTL
Set alert
1.42 USD -0.10 -6.58%
At close
1.45 +0.03 +2.11%
Pre-market · Nov 3, 6:44 AM ET
1.39 Day range 1.56
1.18 52-week range 2.58
- YTD
- -28.64%
- 1 year
- -8.97%
- Open
- 1.55
- Prev close
- 1.52
- Mkt cap
- 377.95M
- Vol
- 4.70M
- Avg vol
- 2.14M
- EPS
- -1.06
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.39
- High
- 1.56
- Forward P/E
- -3.08
- Beta
- 0.00
- Short ratio
- 2.48
- Inst. own
- 77.47%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 3.39
- 200-d avg
- 4.08
- 1y target
- 10.45
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 10.45 +635.9% upside
Now 1.42
- Target (low)
- 7.60
- Target (mean)
- 10.45
- Target (high)
- 13.00
Ratings (0m) 10 10 buy · 0 hold · 0 sell
- Strong buy2
- Buy8
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 10
- 2 months ago 10
- 3 months ago 10
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.22411 | -0.25 – -0.13 | -0.45 | +50.2% | 2.98M | 0.0% | 6 |
| Next quarter | -0.22 | -0.24 – -0.19 | -0.24 | +8.3% | 17.52M | +73.6% | 3 |
| Current year | -0.83854 | -0.92 – -0.67 | -1.20 | +30.1% | 17.33M | +920.4% | 8 |
| Next year | -0.74316 | -0.93 – -0.52 | -0.83854 | +11.4% | 57.90M | +234.2% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 9, 2024 | Needham | Reiterated | Buy | Buy |
| Dec 5, 2024 | Needham | Reiterated | Buy | Buy |
| Nov 18, 2024 | Goldman Sachs | Upgrade | Neutral | Buy |
| Nov 15, 2024 | Redburn Atlantic | Upgrade | Neutral | Buy |
| Nov 13, 2024 | Needham | Reiterated | Buy | Buy |
| Nov 12, 2024 | Needham | Maintained | Buy | Buy |
| Nov 11, 2024 | Needham | Reiterated | Buy | Buy |
| Jun 17, 2024 | Needham | Reiterated | Buy | Buy |
| Jun 3, 2024 | Needham | Reiterated | Buy | Buy |
| May 17, 2024 | Needham | Reiterated | Buy | Buy |
| Apr 12, 2024 | Needham | Reiterated | Buy | Buy |
| Apr 9, 2024 | Truist Securities | Maintained | Buy | Buy |
| Mar 18, 2024 | Truist Securities | Maintained | Buy | Buy |
| Mar 14, 2024 | Needham | Maintained | Buy | Buy |
| Feb 12, 2024 | Needham | Maintained | Buy | Buy |
| Jan 22, 2024 | Needham | Maintained | Buy | Buy |
| Dec 13, 2023 | Goldman Sachs | Maintained | Neutral | Neutral |
| Nov 29, 2023 | Needham | Reiterated | Buy | Buy |
| Nov 9, 2023 | Deutsche Bank | Initiated | — | Buy |
| Oct 25, 2023 | Needham | Reiterated | Buy | Buy |
| Aug 17, 2023 | Truist Securities | Maintained | Buy | Buy |
| Jun 5, 2023 | Needham | Reiterated | Buy | Buy |
| Jun 2, 2023 | Needham | Reiterated | — | Buy |
| May 5, 2023 | Wells Fargo | Maintained | — | Overweight |
| May 5, 2023 | Needham | Reiterated | — | Buy |
| Apr 28, 2023 | Needham | Reiterated | — | Buy |
| Apr 21, 2023 | Needham | Reiterated | — | Buy |
| Mar 8, 2023 | Mizuho | Maintained | — | Buy |
| Mar 7, 2023 | Needham | Reiterated | — | Buy |
| Dec 9, 2022 | Needham | Maintained | — | Buy |